Checkpoint Therapeutics
Stock Forecast, Prediction & Price Target

	Passed			Analyst forecast
Metric	12/31/2021	12/31/2022	12/31/2023	12/31/2025	12/31/2026	12/31/2027
Revenue % change YoY	$268K N/A	$192K -28.35%	$103K -46.35%	Avg: $60.52M Low: $60.52M High: $60.52M avg. 58665.53%	Avg: $95.6M Low: $95.6M High: $95.6M avg. 57.94%	Avg: $239.8M Low: $239.8M High: $239.8M avg. 150.83%
Net Income % change YoY	$-56.61M N/A	$-66.91M -18.18%	$-51.84M 22.51%	Avg: $-2.81M Low: $-3.74M High: $749.69K avg. 94.57%	Avg: $45.16M Low: $45.16M High: $45.16M avg. 1705.73%	Avg: $79.28M Low: $79.28M High: $79.28M avg. 75.51%
EBITDA % change YoY	$-56.72M N/A	$-53.88M 5.00%	$-52.14M 3.21%	Avg: $-60.52M Low: $-60.52M High: $-60.52M avg. -16.07%	Avg: $-95.6M Low: $-95.6M High: $-95.6M avg. -57.94%	Avg: $-239.8M Low: $-239.8M High: $-239.8M avg. -150.83%
EPS % change YoY	-$7.45 N/A	-$7.57 -1.61%	-$2.77 63.40%	Avg: -$0.08 Low: -$0.2 High: $0.04 avg. 97.11%	Avg: $2.41 Low: $2.41 High: $2.41 avg. 3112.50%	Avg: $4.23 Low: $4.23 High: $4.23 avg. 75.51%
Operating Expenses % change YoY	$56.99M N/A	$58.52M 2.69%	$52.25M -10.72%	Avg: $2.09B Low: $2.09B High: $2.09B avg. 3911.20%	Avg: $3.31B Low: $3.31B High: $3.31B avg. 57.94%	Avg: $8.30B Low: $8.30B High: $8.30B avg. 150.83%

FAQ

Wall Street analysts estimate the annual average earnings growth rate of 625.27% in 2025-2027.

We have gathered data from 1 analysts. Their low estimate is -3.74M, average is -2.81M and high is 749.69K.

Wall Street analysts forecast annual average revenue growth of 19624.77% in 2025-2027.

We have gathered data from 1 analysts. Their low revenue estimate is $60.52M, average is $60.52M and high is $60.52M.

Wall Street analysts forecast annual average earnings growth of 1095.04% in 2025-2027.

We have gathered data from 1 analysts. Their low earnings per share estimate is -$0.2, average is -$0.08 and high is $0.04.